Literature DB >> 12966519

Mutations in CYP11B1 gene: phenotype-genotype correlations.

Yuan-Shan Zhu1, Juan J Cordero, Selcuk Can, Li-Qun Cai, Xueke You, Cecilia Herrera, Mariano DeFillo-Ricart, Cedric Shackleton, Julianne Imperato-McGinley.   

Abstract

11beta-hydroxylase deficiency, an autosomal recessive disorder, is the second most common cause of congenital adrenal hyperplasia. We studied four subjects with classic 11beta-hydroxylase deficiency and severe hypertension: a 46,XX affected subject from a Turkish family with severe ambiguity of the external genitalia and hypertension, and three affected 46,XY subjects from a Dominican kindred with isosexual precocious puberty and severe hypertension. The affected subjects had significantly elevated plasma 11-desoxycortisol, 11-desoxycorticosterone, Delta4-androstenedione, and testosterone. To determine the molecular genetic defects, genomic DNA was isolated from the leukocytes of affected subjects and their family members. The encoding region of the 11beta-hydroxylase gene (CYP11B1) was amplified by PCR with specific primers. Using single-stranded DNA conformational polymorphism (SSCP) and DNA sequencing, a nonsense mutation in exon 6 of CYP11B1 in the affected 46,XX subject from the Turkish family was identified, where a cytosine was substituted by a thymidine, resulting in the replacement of glutamine (CAG) by a stop codon (TAG) at amino acid position 338 (Q338X). In the three 46,XY Dominican boys, the mutation was also a nonsense mutation in exon 6 of CYP11B1, where a cytosine was substituted by a thymidine, resulting in the replacement of glutamine (CAG) by a stop codon (TAG) at amino acid position 356 (Q356X). Both mutations result in the biosynthesis of a truncated 11beta-hydroxylase protein with loss of enzymatic activity. Heterozygosity was determined in family members of both probands including parents and siblings. These results indicate that mutations of CYP11B1 in these subjects are responsible for their clinical syndromes. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12966519     DOI: 10.1002/ajmg.a.20108

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

Review 1.  The next 150 years of congenital adrenal hyperplasia.

Authors:  Adina F Turcu; Richard J Auchus
Journal:  J Steroid Biochem Mol Biol       Date:  2015-06-03       Impact factor: 4.292

Review 2.  Insights on the phenotypic heterogenity of 11β-hydroxylase deficiency: clinical and genetic studies in two novel families.

Authors:  Luciana Pinto Valadares; Alessandra Christine Vieira Pfeilsticker; Selma Moreira de Brito Sousa; Sarah Caixeta Cardoso; Olivia Laquis de Moraes; Luiz Claudio Gonçalves de Castro; Renata Santarem de Oliveira; Adriana Lofrano-Porto
Journal:  Endocrine       Date:  2018-09-21       Impact factor: 3.633

Review 3.  Congenital adrenal hyperplasia caused by compound heterozygosity of two novel CYP11B1 gene variants.

Authors:  I Fylaktou; P Smyrnaki; A Sertedaki; M Dracopoulou; Ch Kanaka-Gantenbein
Journal:  Hormones (Athens)       Date:  2021-10-26       Impact factor: 2.885

Review 4.  Clinical and molecular review of atypical congenital adrenal hyperplasia.

Authors:  Taninee Sahakitrungruang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-03-31

5.  Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism.

Authors:  Karl-Heinz Storbeck; Lina Schiffer; Elizabeth S Baranowski; Vasileios Chortis; Alessandro Prete; Lise Barnard; Lorna C Gilligan; Angela E Taylor; Jan Idkowiak; Wiebke Arlt; Cedric H L Shackleton
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

6.  A Rare MSH2 Variant as a Candidate Marker for Lynch Syndrome II Screening in Tunisia: A Case of Diffuse Gastric Carcinoma.

Authors:  Maria Kabbage; Jihenne Ben Aissa-Haj; Houcemeddine Othman; Amira Jaballah-Gabteni; Sarra Laarayedh; Sahar Elouej; Mouna Medhioub; Haifa Tounsi Kettiti; Amal Khsiba; Moufida Mahmoudi; Houda BelFekih; Afifa Maaloul; Hassen Touinsi; Lamine Hamzaoui; Emna Chelbi; Sonia Abdelhak; Mohamed Samir Boubaker; Mohamed Mousaddak Azzouz
Journal:  Genes (Basel)       Date:  2022-07-28       Impact factor: 4.141

7.  Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East.

Authors:  Lilia Romdhane; Rym Kefi; Hela Azaiez; Nizar Ben Halim; Koussay Dellagi; Sonia Abdelhak
Journal:  Orphanet J Rare Dis       Date:  2012-08-21       Impact factor: 4.123

8.  Splicing analysis of CYP11B1 mutation in a family affected with 11β-hydroxylase deficiency: case report.

Authors:  Pattaranatcha Charnwichai; Patra Yeetong; Kanya Suphapeetiporn; Vichit Supornsilchai; Taninee Sahakitrungruang; Vorasuk Shotelersuk
Journal:  BMC Endocr Disord       Date:  2016-06-17       Impact factor: 2.763

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.